Skip to content

Circles

A

Autolus Therapeutics plc

AUTL· Nasdaq

A

AUTLAutolus Therapeutics plc

AUTLAutolus Therapeutics plc·Earnings record

Q2 2018

Source filing unavailable

Next · Q3 2018

Q2 2018 · —

Revenue

$443.00K

no prior Q2 2017 on file

Net Income

-$7.65M

no prior Q2 2017 on file

EPS Diluted

-$0.26

no prior Q2 2017 on file

Margins · derived

Net margin-1726.9%

Same quarter

no prior Q2 2017 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Filing lag

Quarterly history

Q2 ’18Q3 ’18 Q4 ’18 Q2 ’19 Q3 ’19 Q4 ’19^d Q1 ’20 Q2 ’20 Q3 ’20…

Autolus Therapeutics plc · CIK 1730463 · Engraved from SEC EDGAR

Thaler ResearchEngraved from SEC EDGAR© 2026 Thaler. All rights reserved.Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Platform

Using AI API SDKs CLI

Research

News Listen Earnings Insiders Holders Compare Metrics

Screener Watchlists Pies Notes Your companies

Learn

Thaler

Thaler Agent Promise Provenance Circles Account Terms Privacy